The Valley Desk

ArticleCirculation. Cardiovascular quality and outcomesPublished

Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lankenau Institute for Medical Research, Thomas Jefferson University, with Main Line Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Circulation. Cardiovascular quality and outcomes
Published
Subject terms
Humans; Atrial Fibrillation; Vitamin K; Fibrinolytic Agents; Anticoagulants; Risk Assessment; Risk Factors; Aged; Female; Male; Randomized Controlled Trials as Topic; Stroke
PubMed ID
38525596
PubMed Central ID
PMC11021147
Added to directory
Source checked

Report a correction or request removal